MedPath

Safety and efficacy of remimazolam versus propofol in aneurysm coil patients

Not Applicable
Conditions
Not Applicable
Registration Number
KCT0008196
Lead Sponsor
Ajou University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
108
Inclusion Criteria

Age 19-65 years patients who are scheduled for unruptured-aneurysm coil embolization

Exclusion Criteria

BMI > 30 kg/m2
Anticipated difficult airway
Anticipated difficult mask ventilation
COPD, astham, pneumonia, active URI
Risk of aspiration
Patients unable to response on verbal command
History of allergies to benzodiazepines
History of allergies to opioids
History of substance abuse/addiction
Pregnant or breastfeeding patients

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the difference between maximum arterial blood pressure and minimum arterial blood pressure
Secondary Outcome Measures
NameTimeMethod
time to eye opening, recall, nasea, vomiting, pain
© Copyright 2025. All Rights Reserved by MedPath